Recent MS Articles
Cooking and Diet in MS–Fight Aches and Pains with a Four Letter Word….FOOD! by Leigh Kreshel and Kelli Wong Effective management of a chronic disease, such as Multiple Sclerosis, can be difficult. The diet in MS is an important factor
by Vernon Rowe, Doug Schell, and Aaron Seacat March is MS Awareness Month. This time of year we as a country focus on MS, a disease that affects more than 400,000 people in the US and is a major crippler
We believe an MRI, just like an EMG, a Sleep Study, an EEG, and nearly every other test we use, is merely an extension of the neurological history and examination. So you need an Open Low Cost MRI that is
Lemtrada-A New Multiple Sclerosis Treatment By Leigh Kreshel and Doug Schell A brand new Multiple Sclerosis Treatment is now available. The FDA just approved Lemtrada on November 14th as a multiple sclerosis treatment. Rowe Neurology Institute and some of our
Nearly nine thousand MS researchers from America and Europe converged on Boston a couple weeks ago for an exciting meeting of shared clinical and basic science research on Multiple Sclerosis. Dr. Vernon Rowe, Dr. Elizabeth Rowe, Dr. John Hunter, and
Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects more than 2.3 million people worldwide. MS is usually diagnosed in patients between 20 and 40 years of age, more commonly in women than in men.
Robert Reed walked into a dermatologist’s office to have a couple moles checked. The bills he received included charges for an “operating room.”
If you want to understand a book, don’t open it in the middle. We at RNI place unusual emphasis on patient histories, even more unusual in this age of numbers-driven healthcare (and numbers-driven everything else, too).
October is designated as Physical Therapy Month and to celebrate the physical therapists from the Multiple Sclerosis Center at Rowe Neurology Institute (RNI) wanted to give something back to an incredible group of patients. On October, 11th 2012, RNI hosted the 3rd Annual Multiple Sclerosis,
MidAmerica Neuroscience Institute’s Doug Schell APRN, MSCN will be providing education and information about MS to patients, family members, and health care professionals at numerous upcoming events. Schell will speak on MS and the medication Gilenya on Thursday, August 30th at 6:00 PM